T

Tvardi Therapeutics Inc
D

TVRD

4.57400
USD
0.10
(2.21%)
مغلق
حجم التداول
1,657
الربح لكل سهم
-2
العائد الربحي
-
P/E
-2
حجم السوق
42,910,267
المقالات

العنوان: Tvardi Therapeutics Inc

القطاع: Healthcare
الصناعة: Biotechnology
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.